{"nctId":"NCT01189292","briefTitle":"Preoperative Single-dose Steroid Application for the Treatment of Nausea and Vomiting After Thyroid Surgery","startDateStruct":{"date":"2011-01"},"conditions":["Thyroidectomy","Thyroid Diseases"],"count":152,"armGroups":[{"label":"Dexamethasone injection","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Dexamethasone"]},{"label":"Placebo (NaCl 0.9%)","type":"PLACEBO_COMPARATOR","interventionNames":["Other: NaCl 0.9%"]}],"interventions":[{"name":"Dexamethasone","otherNames":["Mephameson"]},{"name":"NaCl 0.9%","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age \\> 18\n* Planned partial or total thyroidectomy\n\nExclusion Criteria:\n\n* History of adverse effects to dexamethasone or propyleneglycol or di-natrium-EDTA\n* Patients with chronic pain\n* Necessity for opioids-application in the postoperative course\n* Not possible administration of a cervical block (0.5% bupivacaine at a dose of 20ml)\n* Patients with Diabetes mellitus\n* Pregnancy (test in young women)\n* Glaucoma\n* Patients who received antiemetic therapy within 48h before surgery\n* Patients with acute pain requiring painkillers others than paracetamol or more than single dose NSAR treatment within 48h before surgery\n* Use of psychotropic drugs\n* Incompliant patients\n* Preoperatively high suspicion of malignancy\n* Re-operations","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Incidence of Postoperative Nausea and Vomiting","description":"Compare the postoperative recovery, as determined by postoperative nausea and vomiting (PONV) after preoperative application of single-dose dexamethasone versus saline in patients undergoing partial or total thyroidectomy (primary end-point)\n\n* any PONV event within 48 hours after surgery\n* PONV was measured at 4, 8, 16, 24, 32 and 48 hours after surgery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29","spread":null},{"groupId":"OG001","value":"57","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Postoperative Nausea and Vomiting","description":"Compare the postoperative recovery, as determined by postoperative nausea and vomiting (PONV) after preoperative application of single-dose dexamethasone versus saline in patients undergoing partial or total thyroidectomy (primary end-point)\n\n* any PONV event within 48 hours after surgery\n* PONV was measured at 4, 8, 16, 24, 32 and 48 hours after surgery","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"28","spread":null},{"groupId":"OG001","value":"52","spread":null}]}]}]},{"type":"SECONDARY","title":"Degree of Post Operative Nausea and Vomiting","description":"mild nausea:......single administration of an antiemetic drug\n\nsevere nausea: repeated administration of antiemetic drugs\n\nvomiting:...........at least one vomiting event","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]}]},{"type":"SECONDARY","title":"Degree of Post Operative Nausea and Vomiting","description":"mild nausea:......single administration of an antiemetic drug\n\nsevere nausea: repeated administration of antiemetic drugs\n\nvomiting:...........at least one vomiting event","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]}]},{"type":"SECONDARY","title":"Postoperative Pain After Physical Stress","description":"Compare grade of pain between the treatment (dexamethasone) and the control (saline) group\n\n* Pain was measured using a verbal rating scale ranging from 0 (no pain) to 10 in steps of 1\n* before obtaining the pain rating, patients were asked to turn their heads (physical stress)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.88","spread":"1.52"},{"groupId":"OG001","value":"2.09","spread":"1.73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.88","spread":"1.54"},{"groupId":"OG001","value":"2.01","spread":"1.75"}]}]}]},{"type":"SECONDARY","title":"Length of Hospital Stay","description":"Compare the lengths of hospital stay between the treatment (dexamethasone) and the control (saline) group","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"48.3","spread":"15.7"},{"groupId":"OG001","value":"48.1","spread":"12.6"}]}]}]},{"type":"SECONDARY","title":"Necessary Anesthesiological Medication","description":"Compare the amount of necessary anesthesiologic medication during the operation between the treatment (dexamethasone) and the control (saline) group","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1097","spread":"422"},{"groupId":"OG001","value":"1168","spread":"422"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.944","spread":"1.197"},{"groupId":"OG001","value":"1.978","spread":"1.111"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.427","spread":"0.111"},{"groupId":"OG001","value":"0.444","spread":"0.108"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38.7","spread":"7.3"},{"groupId":"OG001","value":"39.7","spread":"8.3"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":76},"commonTop":["surgical adverse event grade I","temporary hypoparathyroidism","medical adverse events grade 1","hypocalcemia","bleeding requiring reoperation"]}}}